[Effect of yimai jiangya extract on plasma neuropeptide Y level in patients of senile hypertension with qi-deficiency and blood stasis syndrome]

What Was Tested

The paper reports a study of Neuropeptide Y, published as a randomized controlled trial.

To observe the effect of Yimai Jiangya extract (YMJYE) on plasma neuropeptide Y (NPY) level in patients of senile hypertension at stage II with Qi-Deficiency and blood stasis Syndrome (QDBSS).

Radioimmunoassay was used to examine the level of plasma NPY before and after treatment in the two groups.

Who Took Part

The abstract describes 36 patients taking part.

The age groups tagged for this paper are middle-aged adults and older adults, both men and women.

Sixty-eight patients were randomly divided into two groups, 36 patients in the treated group treated with YMJYE and 32 patients in the control group treated with captopine.

How the Study Was Run

In design terms this was a randomized study.

Because people in this Neuropeptide Y study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

Topics PubMed links to this paper include Diagnosis, Differential, Drugs, Chinese Herbal, Hypertension, Medicine, Chinese Traditional, Neuropeptide Y, Phytotherapy and Qi.

What This Means in Plain Language

The paper is a randomized study of Neuropeptide Y in 36 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2000 (Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine), a journal based in China.

More context: the Neuropeptide Y compound page, all human trials.